Template:Appendicitis Antibiotics: Difference between revisions

No edit summary
 
(One intermediate revision by one other user not shown)
Line 21: Line 21:


'''Options:'''
'''Options:'''
*[[Metronidazole]] 50mg IV q8hrs +
*[[Metronidazole]] 500 mg IV q8hrs +
**[[Cefepime]] 50mg/kg IV q12hrs OR
**[[Cefepime]] 50 mg/kg IV q12hrs OR
**[[Ciprofloxacin]] 400mg IV q12hrs OR
**[[Ciprofloxacin]] 400 mg IV q12hrs OR
**[[Levofloxacin]] 750mg IV q24hrs OR
**[[Levofloxacin]] 750 mg IV q24hrs OR
**[[Aztreonam]] 30mg/kg IV q8hrs
**[[Aztreonam]] 30 mg/kg IV q8hrs
*[[Imipenem/Cilastatin]] 25mg/kg IV q6hrs (max 500mg)
*[[Imipenem/Cilastatin]] 25 mg/kg IV q6hrs (max 500mg)
*[[Meropenem]] 20mg/kg IV q8hrs (max 1g)
*[[Meropenem]] 20 mg/kg IV q8hrs (max 1g)
*[[Piperacillin/Tazobactam]] 100mg/kg (max 4.5g) IV q8hrs
*[[Piperacillin/Tazobactam]] 100 mg/kg (max 4.5g) IV q8hrs
''Cautious use should be applied to use of fluoroquinolones in complicated pediatric appendicitis due to the risk of tendon injury''
''Cautious use should be applied to use of [[fluoroquinolones]] in complicated pediatric appendicitis due to the risk of tendon injury''

Latest revision as of 16:08, 30 November 2018

Coverage should extend to E. coli, Klebsiella, Proteus, and Bacteroides (an anaerobe)

Adult Simple Appendicitis

Antibiotic prophylaxis should be coordinated with surgical consult

Options:

Pediatric Simple Appendicitis

Options:

Complicated Appendicitis

Defined as perforation, abscess, or phlegmon

Options:

Cautious use should be applied to use of fluoroquinolones in complicated pediatric appendicitis due to the risk of tendon injury